Back to Clinical Trials

Clinical Trials: Dermatology


Source: Genentech, Inc.
This was a multicenter, prospective, 5-year surveillance study of approximately 5000 Raptiva-treated patients and approximately 500 non-Raptiva treated patients (formerly 2500 comparison patients who were treated with a biologic therapy other than Raptiva) with chronic moderate to severe plaque psoriasis who were candidates for treatment with Raptiva. Read More
Last Updated: 30 Jun 2015
Source: Astellas Pharma Inc
Subjects exposed to alefacept are to be enrolled. Subjects will be contacted every 6 months to gather general health information. Read More
Last Updated: 09 Dec 2013
Source: Galderma
The purpose of this study is to demonstrate that CD5024 1% cream is more effective than its vehicle when applied once daily, at bed time, during a 12 week period in subjects with Papulopustular Rosacea (PPR) and continues to be safe up to 12 months. Read More
Last Updated: 14 Jan 2015
Source: Peplin
The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of actinic keratoses. Read More
Last Updated: 25 Jan 2016
Source: Cipher Pharmaceuticals Inc.
The purpose of this study is to compare the efficacy and safety of CIP-Isotretinoin and a marketed (generic) formulation of isotretinoin when both are administered twice daily with meals. Read More
Last Updated: 04 Jun 2014
Source: LEO Pharma
This is an observational study to assess the long-term safety of Protopic® Ointment for the treatment of atopic dermatitis. Patients whose ages are/were < 16 years at the time of first tacrolimus ointment exposure are eligible to participate. No drug is distributed during this observational trial. Read More
Last Updated: 06 Jul 2016
Source: GlaxoSmithKline
The purpose of this study is to investigate the safety and efficacy of alitretinoin in the treatment of severe chronic hand eczema that does not respond to treatment with potent topical steroids. Read More
Last Updated: 17 Apr 2013
Source: Pfizer
The main purpose of this study is to assess the effect of smoking status on the success of Etanercept therapy in patients with moderate-to-severe psoriasis. Read More
Last Updated: 06 Dec 2016
Source: Astellas Pharma Inc
To evaluate the safety of treating subjects with up to 12 additional doses of alefacept. Read More
Last Updated: 04 Sep 2014
Source: Galderma
The purpose of this study is to demonstrate that CD5024 1% cream is more effective than its vehicle when applied once daily, at bed time, during a 12 week period in subjects with Papulopustular Rosacea (PPR) and continues to be safe up to 12 months. Read More
Last Updated: 14 Jan 2015
Source: Centro Studi Gised
This is a multicenter randomized controlled clinical trial evaluating the impact of a structured non pharmacological intervention consisting in intensive weight reduction (qualitative and quantitative changes in diet associated with physical exercise) compared to an intervention based on a simple informative counseling about the utility of weight loss for clinical control of psoriatic disease. Read More
Last Updated: 20 Feb 2013
Source: Pfizer
The primary objectives of the study are to 1) compare the efficacy responses of CP 690,550 (5 mg BID and 10 mg BID) versus placebo following 24 weeks of CP 690,550 treatment and subsequent withdrawal of active treatment at various timepoints during the 16 week double blind active or placebo treatment period; 2) evaluate the regain of efficacy responses of CP 690,550 (5 mg BID and 10 mg BID) following 4 -16 weeks of CP 690,550 treatment withdrawal and ... Read More
Last Updated: 13 May 2014
Source: Galderma
The purpose of this study is to determine whether Adapalene, 0.1% is safe and effective in the treatment of Acne Vulgaris. Read More
Last Updated: 20 Mar 2011
Source: Anterios Inc.
The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of acne. Read More
Last Updated: 27 Jun 2013
Source: Maruho Co., Ltd.
This study is to evaluate the efficacy and safety of M518101 and the dose relationship among two doses of M518101 and placebo in male and female plaque psoriasis patients. Read More
Last Updated: 11 Oct 2015
Source: Galderma
The purpose of this study is to evaluate the safety and efficacy of Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% administered once daily for up to 12 weeks in subjects 9 to 11 years of age with acne vulgaris. Read More
Last Updated: 03 Apr 2013
Source: MEDA Pharma GmbH & Co. KG
This clinical trial serves the purpose to compare the long-term effects of a treatment of actinic keratosis - your skin disorder - using Aldara® 5% cream or Solaraze® 3% gel on the face or the scalp. In particular, it should be found out whether the healing effect of these two medications on the skin lesions (i.e. the damaged skin parts) can be maintained for a prolonged period. Read More
Last Updated: 30 Jan 2013
Source: Celgene Corporation
This study evaluated the effects of an called apremilast. Apremilast works by lowering some of the chemicals that affect psoriasis and therefore improves the symptoms of psoriasis. The purpose of this study was to test apremilast and compare its effects to placebo (an inactive substance which contains no medicine but is in the same form as the drug). This study was able to test for efficacy (improvement of signs and symptoms) and safety of apremilast in ... Read More
Last Updated: 12 Oct 2016
Source: Dermira, Inc.
This is an open-label, long-term safety study of DRM04 Topical Wipes, enrolling up to 660 subjects with primary axillary hyperhidrosis who participated in either the DRM04-HH04 or DRM04-HH05 studies. Read More
Last Updated: 11 Jan 2017
Source: Dow Pharmaceutical Sciences
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris. Read More
Last Updated: 17 Apr 2008
Page 1 of 50